tiprankstipranks
Protagonist Therapeutics Inc (PTGX)
NASDAQ:PTGX
US Market
PTGX
Protagonist Therapeutics
RESEARCH TOOLSreports
Want to see PTGX full AI Analyst Report?

Protagonist Therapeutics (PTGX) Income Statement

739 Followers

Protagonist Therapeutics Income Statement

Last quarter (Q1 2026), Protagonist Therapeutics's total revenue was $56.37M, an increase of 99.03% from the same quarter last year. In Q1, Protagonist Therapeutics's net income was $3.78M. See Protagonist Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 46.02M$ 434.43M$ 60.00M$ 26.58M$ 27.36M
Gross Profit
$ 44.79M$ 434.43M$ 60.00M$ 26.58M$ 27.36M
Operating Expenses
$ 202.92M$ 181.59M$ 153.65M$ 157.95M$ 153.20M
Depreciation and Amortization
$ 1.23M$ 826.00K$ 3.31M$ 3.37M$ 2.77M
EBITDA
$ -128.09M$ 253.67M$ -90.34M$ -128.00M$ -123.07M
Operating Income
$ -158.13M$ 252.84M$ -93.65M$ -131.37M$ -125.84M
Other Income/Expenses
$ 28.82M$ 26.57M$ 14.70M$ 3.98M$ 294.00K
Pretax Income
$ -129.31M$ 279.41M$ -78.95M$ -127.39M$ -125.55M
Net Income
$ -130.15M$ 275.19M$ -78.95M$ -127.39M$ -125.55M
Per Share Metrics
Basic EPS
$ -2.05$ 4.47$ -1.39$ -2.52$ -2.65
Diluted EPS
$ -2.05$ 4.23$ -1.39$ -2.52$ -2.65
Weighted Average Shares Outstanding
 63.57M 61.57M 56.76M 49.04M 46.32M
Weighted Average Shares Outstanding (Diluted)
 63.57M 65.08M 56.76M 49.04M 46.32M
Currency in USD

Protagonist Therapeutics Earnings and Revenue History